Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
Chengmei Sun, Luoan Shen, Zheng Zhang, et al.
Genes (2020) Vol. 11, Iss. 8, pp. 837-837
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Physical Exercise: A Promising Treatment Against Organ Fibrosis
Xiaojie Ma, Bing Liu, Ziming Jiang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 343-343
Open Access | Times Cited: 2
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
F. Fortunato, Rachele Rossi, Maria Sofia Falzarano, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 820-820
Open Access | Times Cited: 57
Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
Jerry R. Mendell, Perry B. Shieh, Craig M. McDonald, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 43
Pubertal induction therapy in pediatric patients with Duchenne muscular dystrophy
Giorgio Sodero, Clelia Cipolla, Donato Rigante, et al.
Journal of Pediatric Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 1
The DMD gene and therapeutic approaches to restore dystrophin
F. Fortunato, Marianna Farnè, Alessandra Ferlini
Neuromuscular Disorders (2021) Vol. 31, Iss. 10, pp. 1013-1020
Closed Access | Times Cited: 42
The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
Caroline Merckx, Boél De Paepe
Metabolites (2022) Vol. 12, Iss. 2, pp. 193-193
Open Access | Times Cited: 31
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
Cédric Happi Mbakam, Gabriel Lamothe, Jacques P. Tremblay
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 31
Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy
W. Douglas Biggar, Andrew J. Skalsky, Craig M. McDonald
Journal of Neuromuscular Diseases (2022) Vol. 9, Iss. 4, pp. 463-476
Open Access | Times Cited: 30
Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study
Norma P. Tavakoli, Dorota Gruber, Niki Armstrong, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 8, pp. 1383-1396
Open Access | Times Cited: 17
Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy
Yuta Horikoshi, Norifumi Kuratani, Ken Tateno, et al.
Medicine (2021) Vol. 100, Iss. 49, pp. e28209-e28209
Open Access | Times Cited: 35
The Interplay of Mitophagy and Inflammation in Duchenne Muscular Dystrophy
Andrea L. Reid, Matthew S. Alexander
Life (2021) Vol. 11, Iss. 7, pp. 648-648
Open Access | Times Cited: 33
Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy
Kay Ohlendieck, Dieter Swandulla
Pflügers Archiv - European Journal of Physiology (2021) Vol. 473, Iss. 12, pp. 1813-1839
Open Access | Times Cited: 33
Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications
Olga V. Sergeeva, Evgeniya Shcherbinina, Noam Shomron, et al.
Nucleic Acid Therapeutics (2022) Vol. 32, Iss. 3, pp. 123-138
Closed Access | Times Cited: 25
TRIM72 Alleviates Muscle Inflammation in mdx Mice via Promoting Mitophagy-Mediated NLRP3 Inflammasome Inactivation
Mengli Wu, Huan Li, Juanjuan He, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 16
Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
Kasun Kodippili, Michael A. Rudnicki
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 16
Synthesis of Phosphorodiamidate Morpholino Oligonucleotides Using Trityl and Fmoc Chemistry in an Automated Oligo Synthesizer
Jayanta Kundu, Atanu Ghosh, Ujjwal Ghosh, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 15, pp. 9466-9478
Closed Access | Times Cited: 22
Exome Sequencing and Optical Genome Mapping in Molecularly Unsolved Cases of Duchenne Muscular Dystrophy: Identification of a Causative X-Chromosomal Inversion Disrupting the DMD Gene
Leoni S. Erbe, Sabine Hoffjan, Sören Janßen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14716-14716
Open Access | Times Cited: 13
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model
Maria Siemionow, Katarzyna Budzynska, Kristina Zalants, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 586-586
Open Access | Times Cited: 4
Exploring the Gut Microbiota–Muscle Axis in Duchenne Muscular Dystrophy
Debora Mostosi, Monica L. Molinaro, Sabrina Saccone, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5589-5589
Open Access | Times Cited: 4
Therapeutic Strategies Targeting DUX4 in FSHD
Laura Le Gall, Eva Sidlauskaite, Virginie Mariot, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2886-2886
Open Access | Times Cited: 28
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs
Xi Xiang, Xiaoying Zhao, Xiaoguang Pan, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 24, pp. 403-415
Open Access | Times Cited: 24
Creatine kinase‐MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy
Sunju Park, Breanne Maloney, Michele Caggana, et al.
Muscle & Nerve (2022) Vol. 65, Iss. 6, pp. 652-658
Open Access | Times Cited: 17
Gene Therapy Strategies for Muscular Dystrophies: Current Insights and Future Directions
Mahintaj Dara, Mehdi Dianatpour, Negar Azarpira, et al.
OBM Genetics (2025) Vol. 09, Iss. 01, pp. 1-35
Open Access
The Effect of Genotype Differences on Cardiac Involvement in Cases Diagnosed with Duchenne Muscular Dystrophy
Gizem Doğan, Gamze Sarıkaya Uzan, Yiğithan Güzin, et al.
Neuropediatrics (2025)
Closed Access
Use of Quantum Dots as Nanotheranostic Agents: Emerging Applications in Rare Genetic Diseases
K M Neethu, Supriya Karmakar, Bijaya Ku Sahoo, et al.
Small (2025) Vol. 21, Iss. 9
Closed Access
Page 1 - Next Page

Scroll to top